Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Retrospective review of baseline practices prior to implementing an enhanced recovery programme.

Cardiology in the young·2026
Same author

Alterations in Metabolites Associated With Umbilical Cord Blood in Monozygotic Twins Discordant for Congenital Heart Disease.

Pediatric discovery·2026
Same author

Should delayed umbilical cord clamping at birth be practised in monochorionic twin pregnancies?

Archives of disease in childhood. Fetal and neonatal edition·2026
Same author

Pulmonary Atresia With Major Aorto-Pulmonary Collateral Arteries (MAPCAs): Timing and Type of Intervention.

Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual·2026
Same author

Anatomic Versus Physiologic Repair in Congenitally Corrected Transposition: A Propensity-Matched European Multicentre Study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Atomic-resolution imaging of gold species at organic liquid-solid interfaces.

Science (New York, N.Y.)·2026

関連する実験動画

Updated: Jun 21, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
04:37

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development

Published on: June 16, 2023

ハイポプラスティック左心症候群

David J Barron1, Mark D Kilby, Ben Davies

  • 1Department of Cardiac Surgery, Birmingham Children's Hospital, Birmingham, UK. david.barron@bch.nhs.uk

Lancet (London, England)
|August 18, 2009
PubMed
まとめ

ハイポプラスティック左心症候群 (HLHS) の管理は,致命的から外科的介入によって治療可能へと進化しました. 現在の戦略は,段階的な処置,新生児移植,およびハイブリッド技術を含んでおり,罹患した子供にとって改善された結果を提供しています.

科学分野:

  • ペディアトリック・カルディオロジー
  • 生まれながらの心不全 生まれながらの心不全
  • 新生児の心臓外科手術について

背景:

  • 低プラスティック左心症候群 (HLHS) は,左心部の発達不全によって特徴づけられる重度の先天性心不全です.
  • 歴史的に見て,HLHSはほぼ致命的な予後を持ち,医療および外科治療の進歩を必要とした.
  • HLHSの複雑さは,出生から成人期までの専門的な多学科管理を必要とします.

研究 の 目的:

  • ハイポプラスティック左心症候群の現在の外科的管理戦略をレビューする.
  • 段階的な緩和,移植,およびハイブリッドアプローチを含む治療の選択肢の進化について議論する.
  • HLHS患者の管理における継続的な課題を青春期と成人期に強調する.

主な方法:

  • HLHSの外科的手法のレビュー,右心室を利用した段階的な緩和に焦点を当てた.
  • 新生児の心臓移植などの代替管理オプションの議論.
  • 外科的および介入的アプローチを組み合わせた革新的なハイブリッド手順の探索.

主要な成果:

  • 手術による介入は,HLHSの生存率を大幅に改善し,以前は致命的な見通しを変えました.
  • 右心室が両方の循環を支える段階的な手順は,現在の管理の礎石です.

さらに関連する動画

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

関連する実験動画

Last Updated: Jun 21, 2026

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development
04:37

Left Atrial Ligation in the Avian Embryo as a Model for Altered Hemodynamic Loading During Early Vascular Development

Published on: June 16, 2023

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
08:22

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart

Published on: April 15, 2020

  • 新生児移植とハイブリッドテクニックは,代替または補助的な治療経路を提供します.
  • 結論:

    • HLHSの外科治療と集中治療の管理は著しく進歩し,患者の予後を改善しました.
    • 進歩にもかかわらず,HLHSの生存者の長期的なケアは,成人期への移行に伴い,継続的な課題を提示しています.
    • 手術技術と総合的なケアにおける継続的なイノベーションは,HLHS患者の治療結果を最適化するために不可欠です.